Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06056011 · ClinicalTrials.gov registry record · NA
Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018
A NA study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- NA
- Development phase
- 373
- Enrollment target
NCT06056011 is a NA study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 373 participants.
The verdict
NCT06056011, a NA study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 373 participants
- Enrollment target
Study Summary
The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.
Interventions
- DEVICE Connex CVSM with Timmy3 module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2025-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06056011
The ClinicalTrials.gov registry entry for NCT06056011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 373 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Connex CVSM with Timmy3 module is the first listed.
NCT06056011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06056011 about?
NCT06056011 is a clinical study titled "Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018". The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.
What is the current status of trial NCT06056011?
This trial is currently completed. It is a NA study. The enrollment target is 373 participants. The study started on 2024-02-19. Estimated completion is 2025-03-18.
What interventions are being tested in trial NCT06056011?
The interventions under investigation include: Connex CVSM with Timmy3 module (DEVICE).
Who is sponsoring clinical trial NCT06056011?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.